Minaris Regenerative Medicine’s leaders and experts are proud to share their knowledge and insight with the cell and gene therapy industry. Please review our current and past blog posts on topics of interest to this emerging industry.
As our knowledge of human biology has grown, the newly found information has been leveraged to devise increasingly complicated treatments. This began with small molecule ...
Maintaining a sterile environment is an absolute must for maintaining product sterility in cell therapy manufacturing. Although the cost of building cleanrooms has ...
The traditional method of achieving scale in manufacturing is, typically, to increase production capacity so that more product can be sold. For example, with medicines ...
Dr. Robert Preti joins The Cell Culture Dish in advance of his upcoming keynote at CBI's Optimization of Cell and Gene Therapy Production Conference. The Cell Culture ...
Cell therapy is still a relatively new form of treatment. As such, not that many cell therapies have successfully reached commercialization. Meeting FDA requirements at ...
As I contemplate the future landscape of this cell and gene-based medicine industry and how best it can be navigated, I am always less certain of precisely what the ...
Taking a new cell therapy from early clinical trials all the way to commercial manufacturing is a long and difficult process that few have completed to date. There are ...
One of the most critical first steps in the development of many cell therapies is having optimized apheresis collections. Starting with variable or low-quality apheresis ...
On Thursday, February 23 from 2:00 – 3:30 PM EST, Sanjin Zvonic, PhD, PCT’s Senior Director, Business Leader, Clinical Cell Therapy Manufacturing, will be speaking as ...